A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative

Pil Højgaard; Louise Klokker; Ana-Maria Orbai; Kim Holmsted; Else M Bartels; Ying Ying Leung; Niti Goel; Maarten de Wit; Dafna D Gladman; Philip J Mease; Lene Dreyer; Lars E Kristensen; Oliver Fitzgerald; William Tillett; Laure Gossec; Philip Helliwell; Vibeke Strand; Alexis Ogdie; Caroline B Terwee; Robin Christensen

doi:10.1016/j.semarthrit.2017.09.002

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative

Pil Højgaard, Louise Klokker, Ana-Maria Orbai, Kim Holmsted, Else M Bartels, Ying Ying Leung, Niti Goel, Maarten de Wit, Dafna D Gladman, Philip J Mease, Lene Dreyer, Lars E Kristensen, Oliver Fitzgerald, William Tillett, Laure Gossec, Philip Helliwell, Vibeke Strand, Alexis Ogdie, Caroline B Terwee, Robin Christensen

Department of Life Sciences

Research output: Contribution to journal › Review article › peer-review

51 Citations (SciVal)

160 Downloads (Pure)

Abstract

BACKGROUND: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled trials (RCTs) was endorsed at the Outcome Measures in Rheumatology (OMERACT) meeting in 2016.

OBJECTIVES: To synthesize the evidence on measurement properties of patient reported outcome measures (PROMs) for PsA and thereby contribute to development of a PsA core outcome measurement set (COMS) as described by the OMERACT Filter 2.0.

METHODS: A systematic literature search was performed in EMBASE, MEDLINE and PsycINFO on Jan 1, 2017 to identify full-text articles with an aim of assessing the measurement properties of PROMs in PsA. Two independent reviewers rated the quality of studies using the COnsensus based standards for the Selection of health Measurement INstruments (COSMIN) checklist, and performed a qualitative evidence synthesis.

RESULTS: Fifty-five studies were included in the systematic review. Forty-four instruments and a total of 89 scales were analyzed. PROMs measuring COS domains with at least fair quality evidence for good validity and reliability (and no evidence for poor properties) included the Stockerau Activity Score for PsA (German), Psoriasis Symptom Inventory, visual analogue scale for Patient Global, 36 Item Short Form Health Survey Physical Function subscale, Health Assessment Questionnaire Disability Index, Bath Ankylosing Spondylitis Functional Index, PsA Impact of Disease questionnaire, PsA Quality of Life questionnaire, VITACORA-19, Functional Assessment of Chronic Illness Therapy Fatigue scale and Social Role Participation Questionnaire.

CONCLUSIONS: At least one PROM with some evidence for aspects of validity and reliability was available for six of the eight mandatory domains of the PsA COS.

Original language	English
Pages (from-to)	654-665
Number of pages	12
Journal	Seminars in Arthritis and Rheumatism
Volume	47
Issue number	5
Early online date	9 Sept 2017
DOIs	https://doi.org/10.1016/j.semarthrit.2017.09.002
Publication status	Published - 1 Apr 2018

Bibliographical note

Keywords

Antirheumatic Agents/therapeutic use
Arthritis, Psoriatic/diagnosis
Humans
Patient Reported Outcome Measures
Quality of Life
Severity of Illness Index

Access to Document

10.1016/j.semarthrit.2017.09.002

GRAPPA_OMERACT_SLR_2017_PHAccepted author manuscript, 3.73 MBLicence: CC BY-NC-ND

Outcome Measures for Randomised Controlled Trials in Psoriatic Arthritis
Tillett, W. (PI)
1/09/16 → 3/07/20
Project: Central government, health and local authorities

Cite this

Højgaard, P., Klokker, L., Orbai, A.-M., Holmsted, K., Bartels, E. M., Leung, Y. Y., Goel, N., de Wit, M., Gladman, D. D., Mease, P. J., Dreyer, L., Kristensen, L. E., Fitzgerald, O., Tillett, W., Gossec, L., Helliwell, P., Strand, V., Ogdie, A., Terwee, C. B., & Christensen, R. (2018). A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism, 47(5), 654-665. https://doi.org/10.1016/j.semarthrit.2017.09.002

Højgaard, P, Klokker, L, Orbai, A-M, Holmsted, K, Bartels, EM, Leung, YY, Goel, N, de Wit, M, Gladman, DD, Mease, PJ, Dreyer, L, Kristensen, LE, Fitzgerald, O, Tillett, W, Gossec, L, Helliwell, P, Strand, V, Ogdie, A, Terwee, CB & Christensen, R 2018, 'A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative', Seminars in Arthritis and Rheumatism, vol. 47, no. 5, pp. 654-665. https://doi.org/10.1016/j.semarthrit.2017.09.002

@article{15ec87ef565f48cd941855f75cd18ca0,

title = "A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative",

abstract = "BACKGROUND: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled trials (RCTs) was endorsed at the Outcome Measures in Rheumatology (OMERACT) meeting in 2016.OBJECTIVES: To synthesize the evidence on measurement properties of patient reported outcome measures (PROMs) for PsA and thereby contribute to development of a PsA core outcome measurement set (COMS) as described by the OMERACT Filter 2.0.METHODS: A systematic literature search was performed in EMBASE, MEDLINE and PsycINFO on Jan 1, 2017 to identify full-text articles with an aim of assessing the measurement properties of PROMs in PsA. Two independent reviewers rated the quality of studies using the COnsensus based standards for the Selection of health Measurement INstruments (COSMIN) checklist, and performed a qualitative evidence synthesis.RESULTS: Fifty-five studies were included in the systematic review. Forty-four instruments and a total of 89 scales were analyzed. PROMs measuring COS domains with at least fair quality evidence for good validity and reliability (and no evidence for poor properties) included the Stockerau Activity Score for PsA (German), Psoriasis Symptom Inventory, visual analogue scale for Patient Global, 36 Item Short Form Health Survey Physical Function subscale, Health Assessment Questionnaire Disability Index, Bath Ankylosing Spondylitis Functional Index, PsA Impact of Disease questionnaire, PsA Quality of Life questionnaire, VITACORA-19, Functional Assessment of Chronic Illness Therapy Fatigue scale and Social Role Participation Questionnaire.CONCLUSIONS: At least one PROM with some evidence for aspects of validity and reliability was available for six of the eight mandatory domains of the PsA COS.",

keywords = "Antirheumatic Agents/therapeutic use, Arthritis, Psoriatic/diagnosis, Humans, Patient Reported Outcome Measures, Quality of Life, Severity of Illness Index",

author = "Pil H{\o}jgaard and Louise Klokker and Ana-Maria Orbai and Kim Holmsted and Bartels, {Else M} and Leung, {Ying Ying} and Niti Goel and {de Wit}, Maarten and Gladman, {Dafna D} and Mease, {Philip J} and Lene Dreyer and Kristensen, {Lars E} and Oliver Fitzgerald and William Tillett and Laure Gossec and Philip Helliwell and Vibeke Strand and Alexis Ogdie and Terwee, {Caroline B} and Robin Christensen",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/j.semarthrit.2017.09.002",

language = "English",

volume = "47",

pages = "654--665",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders",

number = "5",

}

TY - JOUR

T1 - A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis

T2 - A GRAPPA-OMERACT initiative

AU - Højgaard, Pil

AU - Klokker, Louise

AU - Orbai, Ana-Maria

AU - Holmsted, Kim

AU - Bartels, Else M

AU - Leung, Ying Ying

AU - Goel, Niti

AU - de Wit, Maarten

AU - Gladman, Dafna D

AU - Mease, Philip J

AU - Dreyer, Lene

AU - Kristensen, Lars E

AU - Fitzgerald, Oliver

AU - Tillett, William

AU - Gossec, Laure

AU - Helliwell, Philip

AU - Strand, Vibeke

AU - Ogdie, Alexis

AU - Terwee, Caroline B

AU - Christensen, Robin

PY - 2018/4/1

Y1 - 2018/4/1

N2 - BACKGROUND: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled trials (RCTs) was endorsed at the Outcome Measures in Rheumatology (OMERACT) meeting in 2016.OBJECTIVES: To synthesize the evidence on measurement properties of patient reported outcome measures (PROMs) for PsA and thereby contribute to development of a PsA core outcome measurement set (COMS) as described by the OMERACT Filter 2.0.METHODS: A systematic literature search was performed in EMBASE, MEDLINE and PsycINFO on Jan 1, 2017 to identify full-text articles with an aim of assessing the measurement properties of PROMs in PsA. Two independent reviewers rated the quality of studies using the COnsensus based standards for the Selection of health Measurement INstruments (COSMIN) checklist, and performed a qualitative evidence synthesis.RESULTS: Fifty-five studies were included in the systematic review. Forty-four instruments and a total of 89 scales were analyzed. PROMs measuring COS domains with at least fair quality evidence for good validity and reliability (and no evidence for poor properties) included the Stockerau Activity Score for PsA (German), Psoriasis Symptom Inventory, visual analogue scale for Patient Global, 36 Item Short Form Health Survey Physical Function subscale, Health Assessment Questionnaire Disability Index, Bath Ankylosing Spondylitis Functional Index, PsA Impact of Disease questionnaire, PsA Quality of Life questionnaire, VITACORA-19, Functional Assessment of Chronic Illness Therapy Fatigue scale and Social Role Participation Questionnaire.CONCLUSIONS: At least one PROM with some evidence for aspects of validity and reliability was available for six of the eight mandatory domains of the PsA COS.

AB - BACKGROUND: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled trials (RCTs) was endorsed at the Outcome Measures in Rheumatology (OMERACT) meeting in 2016.OBJECTIVES: To synthesize the evidence on measurement properties of patient reported outcome measures (PROMs) for PsA and thereby contribute to development of a PsA core outcome measurement set (COMS) as described by the OMERACT Filter 2.0.METHODS: A systematic literature search was performed in EMBASE, MEDLINE and PsycINFO on Jan 1, 2017 to identify full-text articles with an aim of assessing the measurement properties of PROMs in PsA. Two independent reviewers rated the quality of studies using the COnsensus based standards for the Selection of health Measurement INstruments (COSMIN) checklist, and performed a qualitative evidence synthesis.RESULTS: Fifty-five studies were included in the systematic review. Forty-four instruments and a total of 89 scales were analyzed. PROMs measuring COS domains with at least fair quality evidence for good validity and reliability (and no evidence for poor properties) included the Stockerau Activity Score for PsA (German), Psoriasis Symptom Inventory, visual analogue scale for Patient Global, 36 Item Short Form Health Survey Physical Function subscale, Health Assessment Questionnaire Disability Index, Bath Ankylosing Spondylitis Functional Index, PsA Impact of Disease questionnaire, PsA Quality of Life questionnaire, VITACORA-19, Functional Assessment of Chronic Illness Therapy Fatigue scale and Social Role Participation Questionnaire.CONCLUSIONS: At least one PROM with some evidence for aspects of validity and reliability was available for six of the eight mandatory domains of the PsA COS.

KW - Antirheumatic Agents/therapeutic use

KW - Arthritis, Psoriatic/diagnosis

KW - Humans

KW - Patient Reported Outcome Measures

KW - Quality of Life

KW - Severity of Illness Index

U2 - 10.1016/j.semarthrit.2017.09.002

DO - 10.1016/j.semarthrit.2017.09.002

M3 - Review article

C2 - 29037523

SN - 0049-0172

VL - 47

SP - 654

EP - 665

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

IS - 5

ER -

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Projects

Outcome Measures for Randomised Controlled Trials in Psoriatic Arthritis

Cite this